CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese

Thyroid

Volumn 7, Issue 6, 1997, Pages 843-846

  Yanagawa, Tatsuo ^a   Taniyama, Matsuo ^b   Enomoto, Shou ^b   Gomi, Kiyohide ^a   Maruyama, Hiroshi ^c   Ban, Yoshio ^b   Saruta, Takao ^c  

^a Nerima General Hospital   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; DISEASE ASSOCIATION; FEMALE; GENE STRUCTURE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAVES DISEASE; HUMAN; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031434409     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.843     Document Type: Article

References (27)

1. DeGroot LJ, Quintans J 1989 The causes of autoimmune thyroid disease. Endocr Rev 10:537-562.
2. Weetman AP, McGregor AM 1994 Autoimmune thyroid disease: Further development in our understanding. Endocr Rev 15:788-830.
3. McLachlan SM, Rapoport B 1996 Genetic factors in thyroid disease. In: Braverman LE, Utiger RD, (eds) Werner and Ingbar's The Thyroid. Seventh edition. Lippincott-Raven Publishers, Philadelphia, p 483-496.
4. Yanagawa T, Mangklabruks A, Chang YB, Okamoto Y, Fisfalen ME, Curran PG, DeGroot LJ 1993 Human histocompatibility leukocyte antigen DQA1 " 0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J Clin Endocrinol Metab 76:1569-1574.
5. Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH 1995 Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 80:2112-2117.
6. Uno H, Sasazuki T, Tamai H, Matsumoto H 1981 Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature 292:768-770.
7. Demaine A, Welsh KI, Hawe BS, Farid NR 1987 Polymorphism of the immunoglobulin heavy chain T cell receptor β-chain genes in Graves' disease. Acta Endocrinol (Copenh) 281:149-151.
8. Mangklabruks A, Cox NJ, DeGroot LJ 1991 Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab 73:236-244.
9. Demaine A, Welsh KI, Hawe BS, Farid NR 1987 Polymorphism of the T cell receptor β-chain in Graves' disease. J Clin Endocrinol Metab 65:643-646.
10. Cuddihy RM, Dutton CM, Bahn RS 1995 A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 5:89-95.
11. Kotsa KD, Watson PF, Weetman AP 1997 No association between a thyrotropin receptor gene polymorphism and Graves' disease in the female population. Thyroid 7:31-33.
12. Blackemore AIF, Watson PF, Weetman AP, Duff GW 1995 Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 80:111-115.
13. Cuddihy RM, Bahn RS 1996 Lack of an association between alleles of interleukin-lα and interleukin-1 receptor antagonist genes and Graves disease in a North American Caucasian population. J Clin Endocrinol Metab 81:4476-4478.
14. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ 1995 CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 80:41-45.
15. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MTM, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schit F, Gorus FK, Belgian Diabetes Registry, Tosi R, Pozzilli P, Todd JA 1996 The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 5:1075-1080.
16. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K 1997 CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82:143-146.
17. Chambers CA, Krummel MF, Boitel B, Hurwitz A, Sullivan TJ, Fournier S, Cassell D, Brunner M, Allison JP 1996 The role of CTLA-4 in the regulation of T-cell responses. Immunol Rev 153:27-46.
18. Tivol EA, Schweitzer AN, Sharpe AH 1996 Costimulation and autoimmunity. Curr Opin Immunol 8:822-830.
19. Polymeropoulos MH, Xiao H, Rath DS, Merril CR 1991 Di-nucleotide repeat polymorphism at the human CTLA4 gene. Nucleic Acids Res 19:4018.
20. Woolf B 1995 On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253.
21. McLachlan SM 1993 Editorial: the genetic basis of autoimmune thyroid disease. Time to focus on chromosomal loci other than the major histocompatibility complex (HLA in man). J Clin Endocrinol Metab 77:605A-605C.
22. Roman SH, Greenberg D, Rubinstein P, Wallenstein S, Davies TF 1992 Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab 74:496-503.
23. Okamoto Y, Yanagawa T, Fisfalen ME, DeGroot LJ 1994 Proliferative responses of peripheral blood mononuclear cells from patients with Graves' disease to synthetic peptides epitopes of human thyrotropin receptor. Thyroid 4:37-42.
24. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Greisser H, Mak TW 1996 Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985-988.
25. Todd JA, Farrall M 1996 Panning for gold: Genome-wide scanning for linkage in type 1 diabetes. Hum Mol Genet 5:1443-1448.
26. Shaw G, Kamen R 1986 A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
27. Perkins D, Wang ZM, Donovan C, He HZ, Mark D, Guam GM, Wang YS, Walunas T, Bluestone J, Listman J, Finn PW 1996 Regulation of CTLA-4 expression during T cell activation. J Immunol 156:4154-4159.